Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 57.15B | 56.75B | 56.06B | 44.32B | 37.59B | 34.76B |
Gross Profit | 31.95B | 31.32B | 30.04B | 25.01B | 20.85B | 19.36B |
EBITDA | 5.04B | 4.52B | 5.23B | 4.67B | 4.24B | 3.08B |
Net Income | 1.04B | 1.06B | 1.04B | 973.00M | 1.13B | 696.00M |
Balance Sheet | ||||||
Total Assets | 62.18B | 63.08B | 60.75B | 60.59B | 44.64B | 40.62B |
Cash, Cash Equivalents and Short-Term Investments | 3.33B | 5.57B | 5.55B | 5.74B | 6.50B | 4.22B |
Total Debt | 14.94B | 14.74B | 14.83B | 15.97B | 9.31B | 7.94B |
Total Liabilities | 48.38B | 48.57B | 46.63B | 46.66B | 31.85B | 28.82B |
Stockholders Equity | 12.06B | 12.70B | 12.41B | 12.21B | 11.14B | 10.34B |
Cash Flow | ||||||
Free Cash Flow | 3.25B | 3.39B | 2.71B | 248.00M | 1.04B | 758.00M |
Operating Cash Flow | 5.33B | 5.38B | 5.34B | 2.98B | 3.58B | 3.41B |
Investing Cash Flow | -3.41B | -3.48B | -2.33B | -8.63B | -1.24B | -1.60B |
Financing Cash Flow | -1.92B | -2.07B | -3.40B | 4.85B | -284.00M | -1.02B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | €10.24B | 10.57 | 14.39% | 4.44% | 7.71% | -2.82% | |
70 Outperform | €14.26B | 13.86 | 8.75% | 5.35% | 1.26% | 4.64% | |
68 Neutral | €46.58B | 16.63 | 11.84% | 2.42% | 1.09% | -0.94% | |
68 Neutral | €66.39B | 14.02 | 16.66% | 4.11% | 3.21% | 4.24% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | €10.19B | 12.39 | -46.54% | 6.25% | 8.44% | -937.75% | |
45 Neutral | €13.58B | 143.47 | 0.62% | 1.65% | ― | ― |